Russia has developed a vaccine for the corona virus, Vladimir Putin

 

Russian President Vladimir Putin has claimed that his scientists have developed a vaccine against the coronavirus that has been successful against the coronavirus. "The first vaccine against the coronavirus has been registered this morning," he told government ministers. Putin said the vaccine had been tested on humans for two months and met all standards. However, scientists are also concerned about the speed with which Russia claims to have a successful vaccine against corona.  But Russian President Vladimir Putin has announced on state television that the vaccine, developed at the Gomelia Institute in Moscow, is completely safe and has been given to his daughter. "I know this vaccine is very effective, it strengthens the immune system," Putin said. I repeat that it meets all safety standards. The Russian president has expressed hope that the vaccine will be developed on a large scale. Russia's Ministry of Health has also approved the vaccine. Officials say they plan to launch a large-scale vaccination campaign in October.  The World Health Organization (WHO) last week urged Russia to comply with international guidelines for the development of the Code 19 vaccine, citing concerns about non-compliance with safety standards.  On Tuesday, the World Health Organization said it was in talks with Russian authorities to review the vaccine.  The Russian-made vaccine is not currently on the list of six vaccines released by the World Health Organization that have reached the third stage of clinical trials. At this stage of the trial, a drug is widely tested on humans. Despite rapid advances in vaccine development, most experts believe that no vaccine will be available before mid-2021. In July, Russian scientists said a preliminary trial of a vaccine developed by the Gamalia Institute had been completed.

Last week, the Russian government announced plans to launch a large-scale vaccination campaign against the coronavirus in October. Russian scientists say a preliminary trial of the vaccine has been completed and has yielded successful results. But Russian authorities have already approved the vaccine on thousands of people before the trial, called the Phase III trial.  According to experts, these trials are an important part of the trial phase.  But Russian Health Minister Mikhail Morashko said on Tuesday that the vaccine had proved "very effective and safe". He called it a "victory of humanity" over Code 19.  Russia's claims of developing the corona vaccine have been questioned by medical officials and the media in the United States and Europe.  Last month, Dr. Anthony Fauchi, a leading US epidemiologist, expressed skepticism about trials in China and Russia in an effort to develop vaccines faster. WHO spokesman Christian Lindmeyer told the media on August 4 that "sometimes individual researchers claim to have found something, which is obviously big news." But there is a big difference between finding a clue about a potentially effective vaccine and going through all the steps. Russia's claims of the corona vaccine have been questioned by medical officials and the media in the United States and Europe.  In China, too, the trial is in its final stages meanwhile, China's Synovik Biotech Limited Company on Tuesday began the final phase of testing Code 19 on humans. The vaccine is being tested on 1,620 patients in Indonesia.  The vaccine is being developed in collaboration with the Indonesian state-owned company BioPharma.  Earlier, Synovik said that in the second phase of the trial, the vaccine was found to be safe for humans and that antibodies were found in patients.

A vaccine called coronavirus is one of the few effective vaccines that has reached this stage of testing.

There is an urgency around the world that safety standards should not be compromised in the development of the Code 19 vaccine. Recently, however, there has been growing public pressure on governments to develop vaccines.  According to the World Health Organization, efforts are currently underway in more than 100 locations around the world to develop a successful vaccine against the coronavirus. In four of these locations, the vaccine is in the final stages of testing for human use